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Abstract
Background: Community-acquired pneumonia (CAP) is one of the leading causes of morbidity and mortality
worldwide, often leading to hospital admissions. In Portugal, the factors associated with in-hospital mortality due to
CAP are not fully documented. The aim of this study was to characterize the trends of CAP hospitalization in all age
groups and the factors associated with their mortality between 2000 and 2014.
Methods: We conducted a cross-sectional study using CAP hospitalization data in all age groups, in Portugal
Mainland. Logistic regression was used to identify the factors associated with in-hospital mortality.
Results: Between 2001 and 2011, CAP hospitalization rate increased from 2.8 to 4.3 per 1000 population.
Hospitalization rates were higher in the extreme ages ( ≤ 4 and ≥ 75 years). However, a decrease in the
hospitalization rate and its mortality was observed, in the younger ages.
A total of 548,699 hospitalization CAP episodes, between 2000 and 2014, were analyzed, with male (56.2%) and
elderly ≥65 years (91.7%) predominance, resulting in 101,740 deaths (18.5%). Men had a significantly lower mean
age (64.3 ± 26.4 years versus 67.9 ± 27.5 years; p < 0.001). During the studied 15 years, there was an increase of 45.2%
in the number of annual hospitalizations, concomitant with the admission increase of individuals aged over 75
years. Since 2012 a decrease in hospitalizations and associated deaths were detected.
The increase in age represented a progressive and significant rise in the probability of death, except for the age
group 1–4 years. The age group ≥85 years old (Adjusted OR = 124.256; 95%CI: 97.838–157.807) and males (Adjusted
OR = 1.261; 95%CI: 1.243–1.280) were significantly associated with death risk for CAP hospitalization. After 2010, this
risk decreased (Adjusted OR = 0.961; 95%CI: 0.940–0.982). The main factors affecting mortality were age, sex,
unemployment rate, number of performed procedures and admission quinquennia.
Conclusions: Despite a trend of decrease in CAP hospitalizations and associated death since 2012, the numbers of
in-hospital mortality showed, in the 15 years under analysis, an overall increase over time, mainly associated with
age, in particular very old people ( ≥ 75 years), males and a higher parish unemployment rate. Therefore, the
implementation of CAP preventive measures should be reinforced in these vulnerable groups.
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Introduction
Background
Community-acquired pneumonia (CAP) is one of the
main causes of morbidity and mortality worldwide [1, 2].
Globally, pneumonia, together with other lower respira-
tory tract infections are the leading cause of death from
infectious disease causing 3.0 million deaths worldwide
and being the fourth cause of death from all causes in
2016 [2]. CAP mainly affects the elderly in developed
countries and children in developing countries [2]. Also,
in the European Union (EU) pneumonia remains the
most frequent cause of death from infection and was re-
sponsible for nearly 140,000 deaths in 2015, accounting
for over 30% of all respiratory disease mortality [3].
There are large variations in mortality rates across EU
countries: Portugal, the Slovak Republic and the United
Kingdom have the highest rates of pneumonia mortality
[3]. Despite this epidemiological information, it is diffi-
cult to determine the real burden of CAP in Europe, be-
cause precise data are scarce [4]. The highest incidence
of CAP occurs among young children and older adults
[5], whereas mortality is highest among older adults [6–
8]. Many CAP cases require hospitalization and some
studies report admission rates between 20 and 30% [9,
10]. Several studies have shown that the incidence rates
of hospitalization and the risk of death, vary with age,
with the highest rates occurring in the most extreme age
groups, mainly over 75 years old [1, 10].
Populations worldwide are expected to age signifi-
cantly in the coming decades. In Europe, 25% of the
population is already aged 60 years or over and that
proportion is projected to reach 35% in 2050 and 36% in
2100 [11]. This scenario implies that CAP related out-
come may continue to have a high clinical and economic
impact by the expected increase of hospital admissions,
costs and potentially deaths [9–11].
Despite many studies carried out, in Europe, it remains
difficult to understand discrepancies between countries and
geographic regions [4, 12–16]. The analyses of data from
one or a few hospitals have the potential of introducing
bias. This limitation, however, can be overcome by using
data from large national database samples, making possible
a more robust analysis about the real burden of CAP.
In Portugal, there are some studies that highlight the
evolutionary perspective of CAP hospitalizations on
mainland hospitals of National Health Service, between
2000 and 2009 [13, 17, 18]. However, in these studies,
the phenomenon was explored, a decade ago and only in
the adult population.
The present study aimed to characterize the trends of
CAP hospitalization episodes in all age groups and to
identify the factors associated with their mortality,
during a 15-year period, between 2000 and 2014, in
Portugal Mainland.
Methods
Study design and data collection
A cross-sectional study was conducted using data from
2000 to 2014, on hospitalizations due to CAP. CAP
hospitalization was defined as an episode with the prin-
cipal diagnosis coded as 480–486, from the International
Classification of Diseases (ICD), 9th Revision Clinical
Modification (ICD-9-CM). Patients, in whom pneumo-
nia was not the main diagnosis, were excluded. Data
were obtained from the National Hospital Discharge
Database owned and managed by the Central Adminis-
tration for the Health System of the Portuguese Ministry
of Health. This database contains administrative and
clinical data of all hospital admissions of the public Na-
tional Health Service (NHS) in Portugal (up to 2014, it
only included Portugal Mainland public hospitals).
These data were recorded through the WebGDH com-
puter application (a webpage application with restricted
access) and coded according to diagnoses and performed
procedures, during the hospital stay, by specially trained
health staff using the ICD-9-CM.
Study population encompassed individuals from all age
groups, in Portugal Mainland. For each case, information
was obtained concerning year of hospital admission, age,
sex, unemployment rate of the parish of origin of the
patient (value recorded according to the information from
the demographic census survey of the Portuguese popula-
tion [19, 20], chronologically closer to the hospitalization
episode), length of stay (LOS), number of procedures
performed during hospitalization, and discharge outcome.
The anonymity of the subjects was maintained in all the
analyzed data, thus informed consent was not required.
The study was approved by the Ethics Committee of the
Lisbon Faculty of Medicine (107/19).
Patients ‘parish unemployment rate was calculated as
the number of unemployment persons per 100 active
persons registered in the civil parish of origin of the
patient, according to census information chronologically
closer to the admission episode (2001 Census and 2011
Census) [19, 20].
Statistical analysis
Sociodemographic and clinical variables were analyzed
through descriptive statistics. A comparative analysis
was performed to identify associations between variables
of interest through Student’s t-test for independent
samples in numerical variables or alternatively the non-
parametric U Mann-Whitney test. For the comparative
analysis of the categorical variables, the Chi-square and
the Fisher exact test were used. The statistical analysis
assumed a significance level of 5%.
To identify the factors associated with in-hospital mortal-
ity a binary logistic regression was used. All variables whose
bivariate analysis (Odds Ratio) revealed statistical interest
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(p < 0.20) were included in a multifactorial analysis. The
variables in the final model were chosen using the forward
conditional method, obtaining the adjusted Odds Ratio.
The quality of the adjustment of the multifactorial
model was calculated by the area under the ROC curve
(Receiver Operating Characteristic).
To compare the evolution of hospitalization episodes
over time, a hospitalization rate per 1000 population,
was calculated as the ratio between the number of
hospitalization episodes with the main diagnosis of CAP
and the number of inhabitants of the same year, multi-
plied by 1000. The years of 2001 and 2011 were chosen
because it was possible to determine accurately the
official number of the resident population in Portugal
Mainland, based on that year census’ surveys of the
Portuguese population [19, 20].
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) version 23 (SPSS
Inc., Chicago, IL, USA).
Results
Trends in CAP hospitalization rate
Based on data from 2001 and 2011 census, concerning
the population resident in Portugal Mainland [19, 20], a
CAP population based hospitalization rate was deter-
mined, for these two-time points. Across this period,
CAP hospitalization rate increased from 2.8 to 4.3 per
1000 population, concerning the overall age groups
(Table 1). In both time points, and regarding the studied
age groups, hospitalization rates were higher in the
extreme age groups ( ≤ 4 and ≥ 75 years). However, when
comparing 2001 with 2011, it should be noted that a
decrease in CAP hospitalization rate was detected in the
age group 0–4 years. In adults, in both time points, the
hospitalization rate variation increased progressively
with age, with special relevance in the elderly over 75
years, highlighting the observed increase in the absolute
number of hospitalizations in 2011, compared to 2001.
Between 2001 and 2011, in the age group ≥65 years old,
the CAP hospitalization rate increased from 10.3 (range:
5.2–17.6) to 16.5 (range: 6.3–27.6) per 1000 population.
Trends in CAP hospitalizations and in-hospital mortality
Between 2000 and 2014, a total of 548,699 hospitalization
episodes due to CAP were observed in Portugal Mainland
(Figs. 1 and 2). During this time period, there was an in-
crease in the number of annual hospitalization episodes,
from 29,065 in 2000 to 42,213 in 2014, corresponding to
an overall increase of 45.2%. In the analysis by age group,
unlike to the global trend of increased hospitalizations, a
pattern of decreased hospitalizations was detected in the
group of children under 4 years of age. We also highlight
the increase observed in CAP hospitalizations in the age
groups over 75 years (Fig. 2). However, since 2012, a slight
decrease in the number of hospital admissions was
detected in people over 65 years old.
During the 15-year study period, the mean age of CAP
hospitalized patients increased from 58.1 ± 29.7 years to
70.7 ± 24.0 years (data not shown), with 70% of
hospitalization episodes occurring over 65 years old,
mainly in the age group ≥75 years old (Table 2).
Concerning the absolute number of deaths per year,
there was a steady increase until 2012, followed by a de-
crease in the two consecutive following years (Fig. 1).
The analysis by age group showed that, in 2008, the
deaths in the population with more than 85 years old
exceeded for the first time, the number of deaths in the
age group 75–84 years, becoming since then, the age
group with the highest number of in-hospital deaths
(Fig. 3). Until the end of the period under analysis, des-
pite an observed decrease in the hospital mortality since
2012, the gap between the absolute number of deaths, in
the age groups over 85 and 75–84 years, was still
Table 1 CAP hospitalization rate based on census population and in-hospital mortality, by age groups, in 2001 and 2011
Age
Group
Number of
hospitalization
episodes
CAP hospitalization
rate per 1000
population
Ratio of CAP
hospitalization
rates
In-hospital mortality p-value*
% (n)
2001 2011 2001 2011 2011/2001 2001 2011
0–4 3418 2465 6.7 5.4 0.805 0.3% (11) 0.2% (4) < 0.001
5–14 1163 1097 1.1 1.1 0.964 0.9% (10) 0.4% (4) 0.376
15–24 444 469 0.3 0.4 1.344 5.2% (23) 2.4% (11) < 0.001
25–44 2013 2036 0.7 0.7 1.029 4.9% (98) 5.6% (113) 0.314
45–64 3562 5393 1.5 2.0 1.331 9.4% (333) 10.5% (568) < 0.001
65–74 4910 6311 5.2 6.3 1.214 15.2% (746) 15.8% (995) < 0.001
> 75 11,906 25,571 17.6 27.6 1.562 25.1% (2986) 26.7% (6835) < 0.001
Total 27,416 43,342 2.8 4.3 1.550 15.4% (4207) 19.7% (8530) < 0.001
* p-value refers to the comparison of in-hospital mortality proportion
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increasing, secondary to a higher decrease of deaths in
the age group 75–84 years (Fig. 3).
More than a quarter of CAP in-hospital mortality
occurred within 72 h. In fact, 10.7% of the mortality was
observed within 24 h, 27.5% within 72 h, and 35.9%
within 4 days.
Table 2 presents the comparative analysis of in-
hospital mortality according to socio-demographic and
health variables.
In-hospital mortality, of the overall period under ana-
lysis, was 18.5%, with a predominance of males (56.2%)
and of the age groups ≥65 years (91.7%).
The number of hospitalized men was almost always
higher than that observed in women throughout the life
cycle, except in the population over 85 years, where
women represented 56.9% (data not shown). Men had a
significantly lower mean age (64.3 ± 26.4 years versus
67.9 ± 27.5 years; p < 0.001).
Across time, the percentage of deaths increased over
each 5 years’ time periods. Deceased patients were sig-
nificantly older than surviving patients (80.2 versus 65.9
years). Also, deceased patients were submitted to a
greater number of procedures and presented a slightly
lower LOS (Table 2).
Fig. 1 Number of CAP hospital admissions and deaths per year, between 2000 and 2014
Fig. 2 Evolution of the number of CAP hospital admissions by age group, between 2000 and 2014
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Table 2 Distribution of hospitalization episodes due to CAP as the main diagnosis (n = 548,699) and percentage of in-hospital
mortality, according to sociodemographic and clinical variables, between 2000 and 2014
CAP hospital admission In-hospital mortality
% distribution (n) or Mean (± SD) / median % of Death (n) or Mean (± SD) / median p-value *
Age (years) 65.9 (27.0) / 76 80.2 (12.0)/82 < 0.001
Age Group (years) < 0.001
0–24 12.5 (68486) 0.7% (502)
25–44 5.3 (28962) 4.9% (1411)
45–64 12.4 (67870) 9.7% (6568)
65–74 15.8 (86576) 15.8% (13649)
75–84 30.4 (167038) 23.1% (38568)
≥ 85 23.7 (129762) 31.6% (41042)
Sex < 0.001
Male 55.1 (302219) 18.9% (57136)
Female 44.9 (246479) 18.1% (44604)
Unemployment ratea (%) 10.6 (4.7)/10.4 10.8 (4.6)/10.7 < 0.001
Year of admission < 0.001
2000–2004 27.7 (152069) 16.0% (24342)
2005–2009 33.5 (183659) 18.7% (34359)
2010–2014 38.8 (212971) 20.2% (43039)
Length of stay (days) 10.6 (11,6)/8 10.0 (15.68)/6 < 0.001
Performed procedures (n) 7.9 (3,7)/8 8.5 (4.01)/8 < 0.001
Legend: * - Mann-Whitney test for numerical variables and Chi-square independence test for categorical variables; a - Number of unemployment persons per 100
active persons registered in the civil parish of origin of the user, according to census information chronologically closer to the episode (2001 Census and 2011
Census) [19, 20]
Fig. 3 Evolution of the number of in-hospital CAP mortality by age group, between 2000 and 2014
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Factors associated with in-hospital CAP mortality
The sociodemographic and health variables that showed
greater association with in-hospital mortality were
inserted into a multiple logistic regression analysis
model, thus obtaining the magnitude of the association
through the determination of Odds Ratio and adjusted
Odds Ratio (Table 3).
According to the adjusted Odds Ratio analysis, the
increase in age represented a progressive and significant
raise in the probability of death, except for the age group
1–4 years, who showed a lower probability of death. The
age group ≥85 years old (Adjusted OR = 124.256; 95%CI:
97.838–157.807) and males (Adjusted OR = 1.261;
95%CI: 1.243–1.280) were significantly associated with
death risk for CAP hospitalization. Males had a 26%
increased probability of death, compared to females.
The increase of 1 percentage point in the patients ‘par-
ish unemployment rate represented an increase of 0.5%
in death probability. Concerning the year of admission,
it was observed a decrease in probability of death if the
admission occurred in the last quinquennium (2010–
2014). After 2010, this risk decreased (Adjusted OR =
0.961; 95%CI: 0.940–0.982).
LOS was associated with the death event and each day
of hospitalization represented a decrease of 3.3% in the
probability of death. The number of procedures per-
formed during hospitalization was also associated with
an increased risk of death, with an increase of 3.5% for
each additional procedure.
Figures 4 and 5 represent the comparison of Odds
Ratio and Adjusted Odd-Ratios for probability of death
after hospital admission (sex, year of hospital admission,
unemployment rate, number of days of admission, num-
ber of procedures). After the determination of the ad-
justed Odds Ratio, all variables maintained the same risk
trend verified in the analysis of the crude Odds Ratio,
except for the quinquennium of admission, since hospi-
talizations after 2010 showed a lower risk of death.
The determination of the area under the ROC curve
resulted in 72.2%, which means a good model was
obtained [21].
Discussion
Our study showed that, in the 15 years under analysis,
despite a trend of decrease in CAP hospitalizations and
associated mortality after 2012, the number of
Table 3 Adjusted odds ratio for “death” event according to sociodemographic and clinical variables between 2000 and 2014a (p
value < 0.05)
CAP In-hospital mortality
OR (95% CI) Adjusted OR (95%CI)
Age Group (years)
< 1 1 1
1–4 0.410 (0.294–0.572) 0.564 (0.404–0,787)
5–14 1.201 (0.892–1.619) 1.697 (1.257–2.290)
15–24 7.149 (5.464–9.354) 9.746 (7.435–12.776)
25–44 9.317 (7.310–11.875) 11.862 (9.286–15.154)
45–64 19.492 (15.364–24.729) 26.098 (20.530–33.175)
65–74 34.050 (26.857–43.169) 47.238 (37.183–60.011)
75–84 54.616 (43.097–69.214) 78.158 (61.545–99.256)
≥ 85 84.156 (66.406–106.651) 124.256 (97.838–157.807)
Sex
Male 1.055 (1.041–1.070) 1.261 (1.243–1.280)
Female 1 1
Unemployment ratea 1.013 (1.011–1.014) 1.005 (1.003–1007)
Year of admission
2000–2004 1 1
2005–2009 1.208 (1.186–1.230) 1.047 (1.025–1.069)
2010–2014 1.329 (1.306–1.352) 0.961 (0.940–0.982)
Length of stay 0.994 (0.993–0.995) 0.977 (0.976–0.978)
Number of procedures 1.049 (1.047–1.050) 1.035 (1.033–1.037)
Data was also adjusted for Region of Portugal Mainland and for Major Diagnostic Categories (results not presented);
a - Number of unemployment persons per 100 active persons registered in the civil parish of origin of the user, according to census information chronologically
closer to the episode (2001 Census and 2011 Census) [19, 20]
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admissions and in-hospital mortality increased steadily
over time. In-hospital CAP mortality was mainly associ-
ated with the very old individuals (> 75 years), males,
and patients’ parish unemployment rate.
This transversal large-scale study, over a period of 15
years, based on a retrospective data analysis of hospital
admission episodes and associated mortality is one of
the largest studies of this nature carried out in Portugal,
covering all ages, all public hospitals, and the entire
mainland population, allowing robust results and
comparisons.
Reports on CAP incidence focus mainly on hospitali-
zations and show wide variability across countries,
ranging from 1.48 per 1000 population in England, 2.75
in Germany to 6.27 in Spain [6, 22–24]. Despite our
hospitalization rates (2001/2011) are higher than other
European countries [25], our data are in line with a pre-
vious study in our country [13] and close to reports from
Spain [23, 24]. Furthermore, our age group-specific inci-
dence rates increased with advancing age, with incidence
rates in older adults very similar to those reported in
Spain [24]. This cross-country variability may be related
not only to climate differences and vaccine coverage for
influenza and pneumococcal vaccines, but also to differ-
ences in health system structure and other factors such
as heterogeneity in admission criteria [26].
The steady increase of CAP hospitalizations and asso-
ciated mortality is particularly related to the very old
people (Figs. 2 and 3) and reflects most probably the
demographic changes that occurred in the Portuguese
population during the large study period, with a more
aged population according to 2001 and 2011 census
Fig. 4 Comparison of Odds Ratio and Adjusted Odd-Ratios for probability of death after hospital admission (age group)
Fig. 5 Comparison of Odds Ratio and Adjusted Odd-Ratios for probability of death after hospital admission (sex, year of hospital admission,
unemployment rate, number of days of admission, number of procedures)
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data. However, if we look at the numbers associated with
the growth of the elderly population and the number of
CAP hospitalizations, the increments are disproportion-
ate, taking that in the correspondent period, the growth
of population over 75 years was 37.5%, contrasting with
an increment of 115% of the hospitalization episodes.
This suggests that there are other responsible factors
regardless of the change in the population structure.
Actually, this disproportionate increase may reflect not
only, the weight of ageing, but also the overall impact of
the associated comorbidities in the elderly, as docu-
mented in several studies [25–28]. Furthermore, apart
from the known health consequences of the ageing
process, it has been observed that the older Portuguese
adults, report a low household income and are a vulner-
able group in terms of unhealthy lifestyle behaviors and
poor socioeconomic conditions [29]. In particular, older
people over 75 years of age who live alone represent a
group that is subject to great economic and social
vulnerability [30].
During the analyzed period, there was a decrease in
hospital admissions and corresponding mortality in the
group of children under 4 years, which can be explained
by the introduction in Portugal of 7- and 13-valent
pneumococcal conjugate vaccine in 2001 and 2009, re-
spectively. Although not included in the National
Immunization Program until 2015, their use was widely
recommended by pediatricians for all healthy children,
allowing increasing vaccination coverages, 33–72%
between 2001 and 2013 [31], eventually justifying the re-
duction of hospital admissions and their mortality taking
into account that Streptococcus pneumoniae is the main
etiological agent of CAP [4].
Regarding the in-hospital mortality associated with CAP,
our exploratory model of the factors associated with the
probability of death revealed that the increase in age was
the factor that contributed most to the rise in death prob-
ability, mainly in the very old (> 85 years). In fact, 91.7% of
all deaths occurred in the age group ≥65 years old.
The overall mortality rate was 18.5% over the 15 years
analyzed. This value is higher than that found in several
studies ranging from 4.8 to 14.4% [3, 25, 27, 28], but is
similar to other series of various studies conducted in
Europe [4]. A possible explanation the observed higher in-
hospital mortality rate of CAP may be related to the pro-
gressive ageing of Portugal elderly population where very
older people (aged 85 and over) are observed to be grow-
ing at a faster rate than any other age group. Indeed,
Portugal stands out from the rest of the EU countries, as it
is one of the fastest ageing countries, considering that by
2050 those aged 55 and over should represent almost half
(47.1%) of the total population [32]. In addition, Teixeira-
Lopes hypothesized that the fear of dying at home, of
patients and family members, could explain the inclusion
of many patients with end-of-life pneumonia, especially in
older age groups, and we believe this may have impact on
observed hospital mortality [33].
In one study where three world regions were analyzed,
CAP mortality was 13.3% in Latin America, 9.1% in
Europe and 7.3% in US/Canada [34]. After adjustment
for confounding variables, estimated differences in mor-
tality between the three regions were significantly re-
duced. The factors that contributed to the differences
found were the incidence of H1N1 infection, comorbidi-
ties (cerebrovascular disease), abnormal laboratory
values (elevated blood urea nitrogen), antimicrobial ther-
apy (macrolide use, fluoroquinolone use) and vaccina-
tions (influenza, pneumococcal). Some of these factors,
may explain the numbers observed in our country, how-
ever, given the limitations related to the use of an
administrative database we were unable to include
accurate data concerning the above-mentioned factors.
After 2012, the overall trend of growth in CAP hospi-
talizations and associated mortality changed. This
change, in particular the decrease in the number of
deaths in the last 2 years of the study and a reduction in
the risk of death between 2010 and 2014, may be related
to the creation and implementation of a national pro-
gram for chronic respiratory diseases in 2012 [35, 36].
This program under the guidance of the Directorate-
General of Health was responsible and encouraged the
creation and implementation of respiratory guidelines
and health policies in our country. We highlight the free
introduction of the influenza vaccine in the population
over the age of 65 and in other at-risk groups since the
2012/2013 winter season. In fact, with this public health
policy influenza vaccination coverage rate in the popula-
tion aged 65 and older increased from 43 to 50%,
between 2012 and 2014 [37, 38]. Previous studies have
documented an association between influenza vaccin-
ation and a less severe clinical course of CAP and an im-
proved survival in hospitalized patients with this disease,
during influenza season [39, 40]. Moreover, this reduc-
tion in CAP hospitalizations associated with the
observed risk of death reduction in the five-year period
2011–2014 compared to the previous five-year periods,
may also be related to the introduction in Portugal of
the 13-valent pneumococcal conjugate vaccine, as
referred in the study of Kislaya, where a reduction of
pneumococcal pneumonia admissions in Portuguese
elderly was attributed to the hypothetical indirect effect
(Herd effect) of pneumococcal child vaccination [31].
Our results showed a sex gap, with men presenting
higher numbers of CAP hospitalizations, mortality and a
higher risk of death during hospitalization. These results
are in accordance with other studies that show a sex in-
equality in health indicators associated with hospitaliza-
tions [3, 4, 12, 29], with men presenting consistently
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higher hospitalization rates for CAP, which may be re-
lated to a great number of risk factors, such as smoking,
alcoholism, and exposure to toxic occupational exposure
[3, 29]. The greater ratio of male to female mortality
may also reflect higher rates of smoking in males pre-
disposing to respiratory disease [3, 16].
Our study revealed a mean LOS of 10.6 days and a me-
dian of 8 days which was in line with other reports [3, 29,
34]. Eventual differences between studies and countries
are related to the availability of continuing care outside
the hospital environment [41]. In our model for each day
of hospitalization, the risk of death decreased 2.3%, which
we interpret as a reflex of the interruption of
hospitalization by death, given that more than one-third
of the deaths (35.9%) occurred within the first 4 days of
admission.
There are few reports on the association between the
unemployment rate and health status [42]. In our study,
patients’ parish unemployment rate was positively asso-
ciated with CAP mortality. This is the first study that
links CAP mortality with unemployment rate as a proxy
for the regional economic situation. Given that a higher
unemployment rate may generally be related to a more
adverse economic condition and this has been associated
with increased bacterial pneumonia hospitalization rates
[28], our hospital mortality rates may have been inflated
by the impact of the economic crisis. This relationship
points to the need for specific socioeconomic, regional
and population policies in the most vulnerable groups,
such as the elderly in social deprivation. It also hints that
common spatial processes (environmental-level factors)
may be involved in pneumonia outcome, determining
patterns and geographic variations and justifying future
investigations.
There are limitations to this study. First, it was conducted
using retrospective administrative data, conditioning the
lack of information about comorbidities, microbiologic
etiology, the process of care and influenza/pneumococcal
vaccination status. Also, it was not possible to exclude
patients who lived in nursing homes or in long-term care
institutions in which it was possible, that pneumonia cases
were healthcare related. Second, the ICD-9 codes did not
allow for the exclusion of nosocomial infections as no code
specific to this diagnostic category exists, with the conse-
quent overestimation of CAP hospitalization rates. Third,
changes, across the time period in analysis, concerning
admission guidelines, diagnosis and coding practices might
be probable sources of bias.
Conclusions
Our study reveals a huge burden of CAP hospitalizations
and mortality in the older population, showing that CAP
can be a major public health concern, even in a developed
country, such as Portugal. In-hospital mortality was
particularly related to the ageing process and deprived
socioeconomic conditions. Therefore, implementation of
CAP preventive measures should be reinforced in these
vulnerable groups, concerning smoking cessation, flu, and
pneumococcal vaccinations to reduce the burden, particu-
larly in the older population. Also, our findings highlight
that even small shifts in unemployment rate are associated
with in-hospital CAP mortality, suggesting that unemploy-
ment might be an important social determinant.
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